Interventions for enhancing adherence to treatment in adults with bronchiectasis.

A McCullough, ET Thomas, C Ryan, JM Bradley, B O’Neill, JS Elborn, C Hughes

Research output: Contribution to journalArticle

Abstract

Background
Bronchiectasis is characterised by a widening of the airways, leading to excess mucus production and recurrent infection. It is more
prevalent in women and those in middle age. Many patients with bronchiectasis do not adhere to treatments (medications, exercise
and airway clearance) prescribed for their condition. The best methods to change these adherence behaviours have not been identified.
Objectives
To assess the effects of interventions to enhance adherence to any aspect of treatment in adults with bronchiectasis in terms of adherence and health outcomes, such as pulmonary exacerbations, health-related quality of life and healthcare costs.
Search methods
We searched the Cochrane Airways Group Specialised Register (CAGR), which contains trial reports identified through systematic searches of CENTRAL, MEDLINE, EMBASE, CINAHL, AMED and PsycINFO, from inception to October 2015.
Selection criteria
We planned to include randomised controlled trials (RCTs) of adults with bronchiectasis that compared any intervention aimed at
enhancing adherence versus no intervention, usual care or another adherence intervention. We excluded studies of those who had
bronchiectasis due to cystic fibrosis.
Data collection and analysis
Two review authors (AMcC and ET) independently screened titles, abstracts and full-texts of identified studies.
Main results
Searches retrieved 36 studies reported in 37 articles; no eligible studies were identified.
Authors’ conclusions
We did not identify any studies that assessed the effect of interventions to enhance adherence to treatment in bronchiectasis. Adequately powered, well-designed trials of adherence interventions for bronchiectasis are needed.
LanguageEnglish
Number of pages18
JournalCochrane Database of Systematic Reviews
Early online date18 Nov 2015
DOIs
Publication statusE-pub ahead of print - 18 Nov 2015

Fingerprint

Bronchiectasis
Therapeutics
Quality of Health Care
Mucus
Cystic Fibrosis
MEDLINE
Health Care Costs
Randomized Controlled Trials
Quality of Life
Lung
Health
Infection

Keywords

  • Bronchiectasis [�therapy]
  • Patient Compliance [�psychology]

Cite this

McCullough, A ; Thomas, ET ; Ryan, C ; Bradley, JM ; O’Neill, B ; Elborn, JS ; Hughes, C. / Interventions for enhancing adherence to treatment in adults with bronchiectasis. In: Cochrane Database of Systematic Reviews. 2015.
@article{9fae868d4137411fa0f0c44e401dda62,
title = "Interventions for enhancing adherence to treatment in adults with bronchiectasis.",
abstract = "BackgroundBronchiectasis is characterised by a widening of the airways, leading to excess mucus production and recurrent infection. It is moreprevalent in women and those in middle age. Many patients with bronchiectasis do not adhere to treatments (medications, exerciseand airway clearance) prescribed for their condition. The best methods to change these adherence behaviours have not been identified.ObjectivesTo assess the effects of interventions to enhance adherence to any aspect of treatment in adults with bronchiectasis in terms of adherence and health outcomes, such as pulmonary exacerbations, health-related quality of life and healthcare costs.Search methodsWe searched the Cochrane Airways Group Specialised Register (CAGR), which contains trial reports identified through systematic searches of CENTRAL, MEDLINE, EMBASE, CINAHL, AMED and PsycINFO, from inception to October 2015.Selection criteriaWe planned to include randomised controlled trials (RCTs) of adults with bronchiectasis that compared any intervention aimed atenhancing adherence versus no intervention, usual care or another adherence intervention. We excluded studies of those who hadbronchiectasis due to cystic fibrosis.Data collection and analysisTwo review authors (AMcC and ET) independently screened titles, abstracts and full-texts of identified studies.Main resultsSearches retrieved 36 studies reported in 37 articles; no eligible studies were identified.Authors’ conclusionsWe did not identify any studies that assessed the effect of interventions to enhance adherence to treatment in bronchiectasis. Adequately powered, well-designed trials of adherence interventions for bronchiectasis are needed.",
keywords = "Bronchiectasis [�therapy], Patient Compliance [�psychology]",
author = "A McCullough and ET Thomas and C Ryan and JM Bradley and B O’Neill and JS Elborn and C Hughes",
year = "2015",
month = "11",
day = "18",
doi = "10.1002/14651858.CD011023.pub2",
language = "English",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",

}

Interventions for enhancing adherence to treatment in adults with bronchiectasis. / McCullough, A; Thomas, ET; Ryan, C; Bradley, JM; O’Neill, B; Elborn, JS; Hughes, C.

In: Cochrane Database of Systematic Reviews, 18.11.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interventions for enhancing adherence to treatment in adults with bronchiectasis.

AU - McCullough, A

AU - Thomas, ET

AU - Ryan, C

AU - Bradley, JM

AU - O’Neill, B

AU - Elborn, JS

AU - Hughes, C

PY - 2015/11/18

Y1 - 2015/11/18

N2 - BackgroundBronchiectasis is characterised by a widening of the airways, leading to excess mucus production and recurrent infection. It is moreprevalent in women and those in middle age. Many patients with bronchiectasis do not adhere to treatments (medications, exerciseand airway clearance) prescribed for their condition. The best methods to change these adherence behaviours have not been identified.ObjectivesTo assess the effects of interventions to enhance adherence to any aspect of treatment in adults with bronchiectasis in terms of adherence and health outcomes, such as pulmonary exacerbations, health-related quality of life and healthcare costs.Search methodsWe searched the Cochrane Airways Group Specialised Register (CAGR), which contains trial reports identified through systematic searches of CENTRAL, MEDLINE, EMBASE, CINAHL, AMED and PsycINFO, from inception to October 2015.Selection criteriaWe planned to include randomised controlled trials (RCTs) of adults with bronchiectasis that compared any intervention aimed atenhancing adherence versus no intervention, usual care or another adherence intervention. We excluded studies of those who hadbronchiectasis due to cystic fibrosis.Data collection and analysisTwo review authors (AMcC and ET) independently screened titles, abstracts and full-texts of identified studies.Main resultsSearches retrieved 36 studies reported in 37 articles; no eligible studies were identified.Authors’ conclusionsWe did not identify any studies that assessed the effect of interventions to enhance adherence to treatment in bronchiectasis. Adequately powered, well-designed trials of adherence interventions for bronchiectasis are needed.

AB - BackgroundBronchiectasis is characterised by a widening of the airways, leading to excess mucus production and recurrent infection. It is moreprevalent in women and those in middle age. Many patients with bronchiectasis do not adhere to treatments (medications, exerciseand airway clearance) prescribed for their condition. The best methods to change these adherence behaviours have not been identified.ObjectivesTo assess the effects of interventions to enhance adherence to any aspect of treatment in adults with bronchiectasis in terms of adherence and health outcomes, such as pulmonary exacerbations, health-related quality of life and healthcare costs.Search methodsWe searched the Cochrane Airways Group Specialised Register (CAGR), which contains trial reports identified through systematic searches of CENTRAL, MEDLINE, EMBASE, CINAHL, AMED and PsycINFO, from inception to October 2015.Selection criteriaWe planned to include randomised controlled trials (RCTs) of adults with bronchiectasis that compared any intervention aimed atenhancing adherence versus no intervention, usual care or another adherence intervention. We excluded studies of those who hadbronchiectasis due to cystic fibrosis.Data collection and analysisTwo review authors (AMcC and ET) independently screened titles, abstracts and full-texts of identified studies.Main resultsSearches retrieved 36 studies reported in 37 articles; no eligible studies were identified.Authors’ conclusionsWe did not identify any studies that assessed the effect of interventions to enhance adherence to treatment in bronchiectasis. Adequately powered, well-designed trials of adherence interventions for bronchiectasis are needed.

KW - Bronchiectasis [�therapy]

KW - Patient Compliance [�psychology]

UR - http://uir.ulster.ac.uk/35205/1/McCullough%202015.pdf

U2 - 10.1002/14651858.CD011023.pub2

DO - 10.1002/14651858.CD011023.pub2

M3 - Article

JO - Cochrane Database of Systematic Reviews

T2 - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

ER -